Informa plc (LON:INF – Get Free Report) insider Stephen Carter sold 330,249 shares of the company’s stock in a transaction dated Thursday, January 22nd. The shares were sold at an average price of GBX 934, for a total transaction of £3,084,525.66.
Informa Trading Down 2.6%
LON:INF traded down GBX 24.46 during midday trading on Monday, hitting GBX 909.80. The stock had a trading volume of 218,683,922 shares, compared to its average volume of 16,372,407. The stock has a 50-day moving average of GBX 906.04 and a 200 day moving average of GBX 903.43. The company has a market capitalization of £11.63 billion, a price-to-earnings ratio of 165.42, a PEG ratio of 0.75 and a beta of 1.12. Informa plc has a one year low of GBX 634.20 and a one year high of GBX 1,000. The company has a quick ratio of 1.70, a current ratio of 0.56 and a debt-to-equity ratio of 31.98.
Analyst Ratings Changes
INF has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Panmure Gordon restated a “buy” rating and issued a GBX 1,200 target price on shares of Informa in a research report on Wednesday, November 19th. JPMorgan Chase & Co. cut their target price on Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating on the stock in a research report on Monday, January 12th. Berenberg Bank reiterated a “buy” rating and set a GBX 1,030 price target on shares of Informa in a research note on Wednesday, January 21st. Finally, UBS Group restated a “buy” rating and set a GBX 1,055 price objective on shares of Informa in a research report on Friday, November 7th. Six equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Informa presently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,097.86.
About Informa
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
Further Reading
- Five stocks we like better than Informa
- The DoD Just Got A New Drone Supplier
- Your Signature Is Missing – Act Before It’s Too Late
- What Expenses Can Be Deducted From Capital Gains Tax?
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.
